Kaplan Fox Continues to Alert Investors of Microvast Holdings, Inc. (NASDAQ: MVST) to a Class Action Deadline on September 21, 2026

Kaplan Fox filed a securities class action against Microvast on behalf of investors who held shares between April 1, 2025 and March 16, 2026, alleging misleading claims regarding margin targets and the timing of its Huzhou Phase 3.2 expansion. Microvast's Q4 2025 gross margin reportedly fell to about 1% from roughly 36% a year earlier due to inventory impairment charges, while revenue declined 15% year over year to $96.5 million. The complaint also cites a Grizzly Research report alleging overstated production activity and commercial opportunities; the lead-plaintiff deadline is September 21, 2026.

Analysis

The actionable issue is not the lawsuit itself—plaintiff-firm notices rarely alter enterprise value—but the evidence it spotlights: a collapse in gross-margin conversion alongside inventory impairment suggests both demand forecasting and product mix are impaired. For MVST, this raises the probability that working capital remains a cash consumer and that any capacity-related fixed-cost absorption benefits are deferred; the market should apply a lower revenue multiple until management demonstrates normalized utilization and repeatable positive gross margin. The key near-term question is whether the impairment was a discrete legacy-ESS event or signals recurring obsolescence risk in a fast-changing battery supply chain.

Over the next 1-3 months, monitor the next earnings release for inventory days, operating cash flow, backlog conversion, customer concentration, and a reconciliation of installed versus utilized Huzhou capacity. A further revenue-guide reduction or gross margin remaining below the mid-teens would make a financing/dilution scenario materially more likely over the following 6-18 months, particularly if customer platform launches continue slipping. Conversely, independently verifiable capacity commissioning, sequential inventory reduction without further write-downs, and gross margin recovery above 15% would weaken the bear case.

Second-order read-through to battery peers is limited: this appears more company-specific than a broad EV-battery demand signal, since the vulnerability is specialized inventory and commercial-vehicle rollout timing rather than commodity input costs. The contrarian case is that a low absolute valuation may already embed operational distress; therefore, shorting after litigation-driven weakness offers poor asymmetry unless fresh operating data confirms another cash-flow or margin disappointment. BAC has no evident fundamental linkage and should not be traded on this item.

Key Decisions for Investors

• Avoid initiating a directional MVST long ahead of the next earnings report; require evidence of positive operating cash flow and gross margin above 15% before reassessing a recovery position.
• For existing MVST exposure, reduce or hedge into any lawsuit-headline bounce over the next days to weeks; retain only a tightly sized position until inventory, capacity-utilization, and liquidity disclosures are independently verifiable.
• Watch for a renewed short setup only if management cuts revenue guidance, reports another inventory charge, or guides to continued sub-10% gross margin. Use a defined-risk put spread rather than an outright short given elevated squeeze risk in a small-cap EV-battery name.
• Set a thesis-invalidating alert for two consecutive quarters of sequential margin improvement, declining inventory, and no incremental equity/debt financing; those conditions would indicate the impairment was likely non-recurring rather than structural.
• No action in BAC: it is included in the ticker data but has no discernible earnings, balance-sheet, or legal exposure to MVST's shareholder litigation.